[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100628761":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":10,"centralContacts":31,"locations":40,"responsibleParty":178,"collaborators":180,"id":186,"slug":10,"hasResults":187,"nctId":188,"briefTitle":189,"officialTitle":189,"acronym":190,"eligibilityCriteria":191,"healthyVolunteers":192,"sex":193,"minAge":194,"maxAge":10,"enrollmentInfo":195,"targetDuration":10,"studyType":198,"phases":199,"briefSummary":201,"conditions":202,"keywords":10,"overallStatus":43,"whyStopped":10,"lastUpdateSubmitDate":206,"lastUpdatePostDateStruct":207,"startDateStruct":210,"completionDateStruct":212,"leadSponsor":214,"locationsCount":215},{"fullName":5,"class":6},"Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)","OTHER",[8,14],{"label":9,"type":6,"description":10,"interventionNames":11},"Case Group",null,[12,13],"Diagnostic Test: Blood sample collection for telomere biomarker analysis","Diagnostic Test: Telomere biomarker analysis",{"label":15,"type":6,"description":16,"interventionNames":17},"Control Group","Cohort A (High Risk Control) and Cohort B (Low Risk Control)",[12,13],[19,26],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DIAGNOSTIC_TEST","Blood sample collection for telomere biomarker analysis","Peripheral blood samples will be collected to measure telomere-related biomarkers that will be used for the development of a predictive algorithm.",[9,15],[25],"Blood sample",{"type":20,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"Telomere biomarker analysis","Laboratory analysis of telomere-associated biomarkers in blood samples to generate data for the development of a predictive clinical algorithm.",[9,15],[25],[32,37],{"name":33,"role":34,"phone":35,"phoneExt":10,"email":36},"Antonio Cubillo, MD","CONTACT","917 56 79 97","acubillo@hmhospitales.com",{"name":38,"role":34,"phone":10,"phoneExt":10,"email":39},"Paloma Peinado, MD","ppeinado@hmhospitales.com",[41,58,70,79,93,105,113,122,131,140,153,165],{"facility":42,"status":43,"city":44,"state":45,"zip":10,"country":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Hospital General Universitario de Elche","RECRUITING","Elche","Alicante","Spain",{"type":48,"coordinates":49},"Point",[50,51],-0.70107,38.26218,{"lat":51,"lon":50},[54,56],{"name":55,"role":34,"phone":10,"phoneExt":10,"email":10},"Javier David Benítez, MD",{"name":55,"role":57,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"facility":59,"status":43,"city":60,"state":60,"zip":10,"country":46,"cosmosGeoPoint":61,"geoPoint":65,"contacts":66},"Hospital del Mar","Barcelona",{"type":48,"coordinates":62},[63,64],2.15899,41.38879,{"lat":64,"lon":63},[67,69],{"name":68,"role":34,"phone":10,"phoneExt":10,"email":10},"Roberto Chalela, MD",{"name":68,"role":57,"phone":10,"phoneExt":10,"email":10},{"facility":71,"status":43,"city":60,"state":60,"zip":10,"country":46,"cosmosGeoPoint":72,"geoPoint":74,"contacts":75},"Institut Catalá D'Oncologia Badalona (ICO)",{"type":48,"coordinates":73},[63,64],{"lat":64,"lon":63},[76,78],{"name":77,"role":34,"phone":10,"phoneExt":10,"email":10},"Maria Saigi, MD",{"name":77,"role":57,"phone":10,"phoneExt":10,"email":10},{"facility":80,"status":43,"city":81,"state":82,"zip":10,"country":46,"cosmosGeoPoint":83,"geoPoint":87,"contacts":88},"Hospital Universitario Marqués de Valdecilla","Santander","Cantabria",{"type":48,"coordinates":84},[85,86],-3.80493,43.46589,{"lat":86,"lon":85},[89,91],{"name":90,"role":34,"phone":10,"phoneExt":10,"email":10},"Marta López-Brea, MD",{"name":92,"role":57,"phone":10,"phoneExt":10,"email":10},"María Lopez-Brea, MD",{"facility":94,"status":43,"city":95,"state":95,"zip":10,"country":46,"cosmosGeoPoint":96,"geoPoint":100,"contacts":101},"Clínica Universidad de Navarra","Madrid",{"type":48,"coordinates":97},[98,99],-3.70256,40.4165,{"lat":99,"lon":98},[102,104],{"name":103,"role":34,"phone":10,"phoneExt":10,"email":10},"Luis Seijó, MD",{"name":103,"role":57,"phone":10,"phoneExt":10,"email":10},{"facility":106,"status":43,"city":95,"state":95,"zip":10,"country":46,"cosmosGeoPoint":107,"geoPoint":109,"contacts":110},"HM Sanchinarro\u002FCIOCC",{"type":48,"coordinates":108},[98,99],{"lat":99,"lon":98},[111,112],{"name":38,"role":34,"phone":10,"phoneExt":10,"email":10},{"name":38,"role":57,"phone":10,"phoneExt":10,"email":10},{"facility":114,"status":43,"city":95,"state":95,"zip":10,"country":46,"cosmosGeoPoint":115,"geoPoint":117,"contacts":118},"Hospital Universitario 12 Octubre",{"type":48,"coordinates":116},[98,99],{"lat":99,"lon":98},[119,121],{"name":120,"role":34,"phone":10,"phoneExt":10,"email":10},"Jon Zugazagoitia, MD",{"name":120,"role":57,"phone":10,"phoneExt":10,"email":10},{"facility":123,"status":43,"city":95,"state":95,"zip":10,"country":46,"cosmosGeoPoint":124,"geoPoint":126,"contacts":127},"Hospital Universitario Clínico San Carlos",{"type":48,"coordinates":125},[98,99],{"lat":99,"lon":98},[128,130],{"name":129,"role":34,"phone":10,"phoneExt":10,"email":10},"Mónica Antoñanzas, MD",{"name":129,"role":57,"phone":10,"phoneExt":10,"email":10},{"facility":132,"status":43,"city":95,"state":95,"zip":10,"country":46,"cosmosGeoPoint":133,"geoPoint":135,"contacts":136},"Hospital Universitario Fundación Jiménez Díaz",{"type":48,"coordinates":134},[98,99],{"lat":99,"lon":98},[137,139],{"name":138,"role":34,"phone":10,"phoneExt":10,"email":10},"Carolina Gotera, MD",{"name":138,"role":57,"phone":10,"phoneExt":10,"email":10},{"facility":141,"status":43,"city":142,"state":143,"zip":10,"country":46,"cosmosGeoPoint":144,"geoPoint":148,"contacts":149},"Hospital Universitario Central de Asturias","Oviedo","Principality of Asturias",{"type":48,"coordinates":145},[146,147],-5.84476,43.36029,{"lat":147,"lon":146},[150,152],{"name":151,"role":34,"phone":10,"phoneExt":10,"email":10},"Lucía García, MD",{"name":151,"role":57,"phone":10,"phoneExt":10,"email":10},{"facility":154,"status":43,"city":155,"state":155,"zip":10,"country":46,"cosmosGeoPoint":156,"geoPoint":160,"contacts":161},"Complejo Hospitalario de Toledo","Toledo",{"type":48,"coordinates":157},[158,159],-4.02263,39.8581,{"lat":159,"lon":158},[162,164],{"name":163,"role":34,"phone":10,"phoneExt":10,"email":10},"Ana Karina Santos, MD",{"name":163,"role":57,"phone":10,"phoneExt":10,"email":10},{"facility":166,"status":43,"city":167,"state":167,"zip":10,"country":46,"cosmosGeoPoint":168,"geoPoint":172,"contacts":173},"Hospital Universitari I Politècnic La Fe","Valencia",{"type":48,"coordinates":169},[170,171],-0.37966,39.47391,{"lat":171,"lon":170},[174,176],{"name":175,"role":34,"phone":10,"phoneExt":10,"email":10},"Andrés Briones, MD",{"name":177,"role":57,"phone":10,"phoneExt":10,"email":10},"Mario Briones, MD",{"type":179,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[181,184],{"name":182,"class":183},"Life Length SL","INDUSTRY",{"name":185,"class":183},"Apices Soluciones S.L.","100628761",false,"NCT07465848","Prospective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer Diagnosis","PneumoTAV001","Inclusion Criteria:\n\nCase Group:\n\n* Person aged 45 years or older at the time of signing the consent form.\n* Person with a current anatomopathologically confirmed diagnosis of small-cell or non-small cell lung cancer.\n* Not having received any oncological treatment prior to sample collection (surgery, radiotherapy, or systemic treatment with chemotherapy or immunotherapy).\n\nControl Group:\n\nCohort A (High risk controls):\n\n* Person aged 45 years or older at the time of signing the consent form.\n* High risk of lung cancer, defined as having a smoking history of at least 20 pack-year and currently smoking or having quit within the past 15 years.\n* No diagnosis or suspicion of lung cancer. Asymptomatic individuals who have undergone a chest computed tomography (CT) scan for lung cancer screening within the 12 months prior to signing the informed consent and as part of routine clinical practice, with a LUNG-RADS score of 3 or lower, will be included.\n\nCohort B (Low-risk controls):\n\n* Person aged 45 years or older at the time of signing the consent form.\n* Without high risk of lung cancer according to the criteria defined in cohort A.\n* No diagnosis or suspicion of lung cancer.\n\nExclusion Criteria:\n\n* History of any malignant neoplasm, except for subjects with tumors in localized stages who have undergone radical treatment and have been disease-free for at least five years.\n* Patient diagnosed with lung cancer who has already started oncological treatment before sample collection.\n* Patient who has undergone a biopsy or any invasive procedure or minor surgery less than 48 hours ago.\n* Patient who has undergone major surgery less than 7 days ago.\n* Patient with severe chronic kidney disease, defined as a glomerular filtration rate below 15 ml\u002Fmin.\n* Patient with severe liver disease, defined as Child-Pugh C.\n* Active infection, or treated less than 4 weeks ago.\n* Vulnerable population, for example, minors, prisoners, pregnant women, adults physically or mentally incapable of giving consent.",true,"ALL","45 Years",{"count":196,"type":197},1200,"ESTIMATED","INTERVENTIONAL",[200],"NA","This research is a clinical performance study of in vitro diagnostic device (IVD), a prospective, multicentre, open-label, case-control clinical investigation aimed at constructing a predictive model that allows results to be classified as positive or negative in relation to the probability of having lung cancer.",[203,204,205],"Lung Cancer (Diagnosis)","Health Adult Subjects","Patient","2026-03-09",{"date":208,"type":209},"2026-03-12","ACTUAL",{"date":211,"type":209},"2025-10-08",{"date":213,"type":197},"2026-12-31",{"name":5,"class":6},12]